- Filed
- Aug 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Aug 7, 2024 | 12.8M sh |
| Cash And Equivalents | Q2 2024 · Jun 30, 2024 | $2.62M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $2.57M |
| Current Liabilities | Q2 2024 · Jun 30, 2024 | $726.02K |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $1.01M |
| Total Liabilities | Q2 2024 · Jun 30, 2024 | $726.02K |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $1.02M |
| Current Assets | Q2 2024 · Jun 30, 2024 | $11.87M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $11.68M |
| Total Assets | Q2 2024 · Jun 30, 2024 | $11.94M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $11.82M |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 12.82M sh |
| Shares Diluted | Q2 2024 · Jun 30, 2023 | 12.82M sh |
| Dividends Paid | Q2 2024 · Jun 30, 2023 | $1.11M |
| Capex | Q2 2024 · Jun 30, 2023 | $1.47K |
| Operating Cash Flow | Q2 2024 · Jun 30, 2023 | $266.78K |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $10.34M |
| Stockholders Equity | Q2 2024 · Mar 31, 2023 | $11.45M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | $11.32M |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.01 |
| Eps Diluted | Q2 2024 · Jun 30, 2023 | $0.02 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.01 |
| Eps Basic | Q2 2024 · Jun 30, 2023 | $0.02 |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $87.92K |
| Sga Expense | Q2 2024 · Jun 30, 2023 | $221.68K |
| Net Income | Q2 2024 · Jun 30, 2023 | $176.43K |
| Net Income | Q2 2024 · Jun 30, 2023 | $307.54K |
| Net Income | Q2 2024 · Mar 31, 2023 | $131.11K |
| Operating Income | Q2 2024 · Jun 30, 2023 | $145.12K |
| Operating Income | Q2 2024 · Jun 30, 2023 | $227.57K |
| Revenue restated | Q2 2024 · Jun 30, 2023 | $1.32M |
| Revenue restated | Q2 2024 · Jun 30, 2023 | $2.67M |